MNA
UTHR icon

Manning & Napier Advisors’s United Therapeutics UTHR Stock Holding History

Manning & Napier Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81K Buy
+7
New +$3.94K ﹤0.01% 626

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Manning & Napier Advisors's UTHR Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in United Therapeutics (UTHR) in Q2 2026: 7 shares worth $3.81K. The stake represents ﹤0.01% of the portfolio and ranks #626 among its holdings.

874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Manning & Napier Advisors held 7 shares of United Therapeutics worth $3.81K as of Q2 2026.
  • United Therapeutics was a new Manning & Napier Advisors position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #626 holding.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.